[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100563679":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":37,"centralContacts":41,"locations":50,"responsibleParty":70,"collaborators":69,"id":73,"slug":74,"hasResults":75,"nctId":76,"briefTitle":77,"officialTitle":78,"acronym":69,"eligibilityCriteria":79,"healthyVolunteers":75,"sex":80,"minAge":81,"maxAge":69,"enrollmentInfo":82,"targetDuration":69,"studyType":85,"phases":86,"briefSummary":88,"conditions":89,"keywords":93,"overallStatus":53,"whyStopped":69,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":98,"startDateStruct":101,"completionDateStruct":103,"leadSponsor":105,"locationsCount":106},{"fullName":5,"class":6},"Loyola University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Insulin Glargine","ACTIVE_COMPARATOR","Insulin Glargine dosed 1-2 times daily throughout pregnancy for management of diabetes mellitus.",[13],"Drug: Insulin glargine",{"label":15,"type":10,"description":16,"interventionNames":17},"Insulin NPH","Insulin NPH dosed 1-2 times daily throughout pregnancy for management of diabetes mellitus.",[18],"Drug: insulin NPH",[20,30],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Insulin glargine","Insulin Glargine is regularly used outside of pregnancy and its efficacy is well documented. It is a current medication we regularly use in pregnancy, however, there is limited data for comparison to the standard, NPH.",[9],[26,27,28,29],"Lantus","Toujeo","Basaglar","Semglee",{"type":21,"name":31,"description":32,"armGroupLabels":33,"otherNames":34},"insulin NPH","Insulin NPH is a current medication used in pregnancy for diabetes mellitus. It has been used as the standard form of insulin.",[15],[35,36],"Novolin","Humulin",[38],{"name":39,"affiliation":5,"role":40},"Joana Lopes Perdigao, MD","PRINCIPAL_INVESTIGATOR",[42,47],{"name":39,"role":43,"phone":44,"phoneExt":45,"email":46},"CONTACT","708-216-4033","2","joana.perdigao@lumc.edu",{"name":48,"role":43,"phone":44,"phoneExt":45,"email":49},"Nuong Truong, MD","nuong.t.truong@luhs.org",[51],{"facility":52,"status":53,"city":54,"state":55,"zip":56,"country":57,"countryCode":58,"cosmosGeoPoint":59,"geoPoint":64,"contacts":65},"Loyola University Medical Center","RECRUITING","Maywood","Illinois","60153","United States","US",{"type":60,"coordinates":61},"Point",[62,63],-87.84312,41.8792,{"lat":63,"lon":62},[66,67,68],{"name":39,"role":43,"phone":44,"phoneExt":45,"email":46},{"name":48,"role":43,"phone":44,"phoneExt":45,"email":49},{"name":39,"role":40,"phone":69,"phoneExt":69,"email":69},null,{"type":40,"investigatorFullName":71,"investigatorTitle":72,"investigatorAffiliation":5,"oldNameTitle":69,"oldOrganization":69},"Joana Perdigao","Assistant Professor","100563679","phase-3-rct-glargine-vs-nph-for-treatment-of-dm-in-pregnancy-100563679",false,"NCT06619301","RCT Glargine vs NPH for Treatment of DM in Pregnancy","Randomized Controlled Trial of Glargine Versus Neutral Protamine Hagedorn Insulin for the Treatment of Diabetes Mellitus in Pregnancy","Inclusion Criteria:\n\n* Patient requiring initiation of insulin therapy for Gestational Diabetes Mellitus or Type 2 Diabetes Mellitus in pregnancy\n* At least 18 years old\n* Insulin started prior to 34 weeks gestation\n* Established prenatal care by 14 weeks gestation\n\nExclusion Criteria:\n\n* Those under the age of 18 years old\n* Those unable to consent in english\n* Allergy to insulin\n* Controlled with only diet modification or the use of oral antihyperglycemics\n* Has diagnosis of Type 1 Diabetes Mellitus\n* Receiving insulin through an insulin pump","FEMALE","18 Years",{"count":83,"type":84},160,"ESTIMATED","INTERVENTIONAL",[87],"PHASE3","We are asking you to take part in this research study because you are diagnosed with pregestational Type 2 Diabetes Mellitus or Gestational Diabetes Mellitus requiring insulin therapy in pregnancy. Currently, many hospitals differ among use of insulin for management of DM in pregnancy, with NPH, glargine and detemir being the most commonly used forms of basal insulin. Outside of pregnancy, NPH is rarely used with glargine and determir being the more common forms of insulin used due to their fewer episodes of hypoglycemia in these patients. Detemir has been well studied in pregnancy and found to be noninferior to NPH. Unfortunately, glargine has not been as well studied in pregnancy. Thus, with this study we want to compare glargine and NPH.\n\nThe purpose of this study is to compare two different forms of insulin (Glargine and NPH) that we regularly use to manage diabetes mellitus in pregnancy.",[90,91,92],"Diabetes Mellitus in Pregnancy","Type 2 Diabetes Mellitus (T2DM)","Gestational Diabetes Mellitus, Class A2",[94,95,96],"Glargine","NPH","Hypoglycemia","2024-09-26",{"date":99,"type":100},"2024-10-01","ACTUAL",{"date":102,"type":100},"2024-04-01",{"date":104,"type":84},"2027-01-01",{"name":5,"class":6},1]